Integrated Biopharma Inc (INBP) — DEF 14A Filings
All DEF 14A filings from Integrated Biopharma Inc. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
INBP Sets Dec. 1 Annual Meeting; Key Director Election, Comp Votes on Tap
— Oct 28, 2025 Risk: low
INTEGRATED BIOPHARMA INC (INBP) is holding its 2025 Annual Meeting on December 1, 2025, to address key governance matters. Stockholders will vote on the electio -
Integrated Biopharma Files Definitive Proxy Statement
— Oct 28, 2024 Risk: low
Integrated Biopharma, Inc. filed a definitive proxy statement (DEF 14A) on October 28, 2024. The filing pertains to the company's proxy materials, which are typ
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX